The funding will support development of a test for the Zika virus using Ontera's silicon nanopore-based molecular diagnostics platform.
Group K said that the partners are developing a RT-LAMP system for use at the point of care in resource-limited areas where real-time RT-PCR is not available.
The company has initial financing of $35 million, and has licensed its foundational SHERLOCK and INSPECTR technologies from the Broad and Harvard, respectively.
The test is designed to identify and differentiate between Zika, dengue, and chikungunya in serum samples, even in the presence of more than one target.
In Cell this week: approach for mapping enhancers and their targets, comparative protein interaction analysis of dengue and Zika viruses, and more.
With long-read sequencing, mapping, and other approaches, researchers assembled a high-quality genome for Aedes aegypti, a notorious infectious disease vector.
Cytokine patterns could be useful as biomarkers for identifying pregnant women whose babies may be at risk of developing Zika-linked abnormalities.
Researchers trained a machine-learning model to predict animal reservoirs or insect vectors for dozens of "orphan" viruses with unknown natural sources.
Using biorepository strains, researchers from the J. Craig Venter Institute and elsewhere profiled Zika virus consensus sequences, variant patterns, and phylogenetics.
The test is designed to detect the presence or absence of the Zika virus in serum or plasma collected alongside urine from patients with suspected infection.
University of California, San Diego researchers investigate how skin care products influence the skin microbiome, Scientific American reports.
Three genetic testing companies form a coalition to influence how Congress considers genetic privacy, The Hill reports.
The Wall Street Journal examines billing codes used by uBiome.
In PNAS this week: links between lung adenocarcinoma and lncRNA, algorithm to impute and cluster Hi-C interaction profiles from single cells, and more.